These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28393576)

  • 1. Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.
    Houghton DE; Key NS; Zakai NA; Laux JP; Shea TC; Moll S
    Leuk Lymphoma; 2017 Nov; 58(11):2573-2581. PubMed ID: 28393576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of anticoagulation in the treatment of venous thromboembolism in patients with haematological malignancies and thrombocytopenia: Report of 5 cases and literature review.
    Lim MS; Enjeti AK
    Crit Rev Oncol Hematol; 2016 Sep; 105():92-9. PubMed ID: 27397486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.
    Al-Samkari H; Connors JM
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):71-79. PubMed ID: 31808892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia.
    Khanal N; Bociek RG; Chen B; Vose JM; Armitage JO; Bierman PJ; Maness LJ; Lunning MA; Gundabolu K; Bhatt VR
    Am J Hematol; 2016 Nov; 91(11):E468-E472. PubMed ID: 27489982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes.
    Samuelson Bannow BT; Walter RB; Gernsheimer TB; Garcia DA
    J Thromb Thrombolysis; 2017 Nov; 44(4):442-447. PubMed ID: 28884390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of anticoagulation in thrombocytopenic patients with hematologic malignancies: A case series.
    Campbell PM; Ippoliti C; Parmar S
    J Oncol Pharm Pract; 2017 Apr; 23(3):220-225. PubMed ID: 26854266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study.
    Kopolovic I; Lee AY; Wu C
    Ann Hematol; 2015 Feb; 94(2):329-36. PubMed ID: 25190031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes.
    Shaw JR; Douketis J; Le Gal G; Carrier M
    J Thromb Haemost; 2019 Jul; 17(7):1171-1178. PubMed ID: 31038838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study.
    Baumann Kreuziger L; Gaddh M; Onadeko O; George G; Wang TF; Oo TH; Jaglal M; Houghton DE; Streiff MB; Gali R; Feng M; Simpson P; Billett HH
    Thromb Res; 2021 Jun; 202():155-161. PubMed ID: 33862470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of thrombocytopenia in patients with acute cancer-associated thrombosis.
    Hsu C; Patell R; Zwicker JI
    Blood Adv; 2023 Sep; 7(17):4721-4727. PubMed ID: 36170802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Kahale L; Barba M; Neumann I; Labedi N; Terrenato I; Sperati F; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006650. PubMed ID: 25004410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopenia.
    Samuelson BT; Gernsheimer T; Estey E; Garcia DA
    Thromb Res; 2016 May; 141():104-5. PubMed ID: 26994682
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single center evaluation on the use of conditionally ordered low molecular weight heparins in malignant hematology patients with venous thromboembolism.
    Pun H; Pang I; Leblanc K; Dhillon P; McEwan C; Patel P; Kumar R
    J Oncol Pharm Pract; 2024 Jul; 30(5):823-829. PubMed ID: 37501557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation.
    Martens KL; Amos CI; Hernandez CR; Kebriaei P; da Costa WL; Basom R; Davis C; Kesten M; Carrier M; Garcia DA; Lee SJ; Li A
    Am J Hematol; 2021 Sep; 96(9):1137-1146. PubMed ID: 34097772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study.
    Carney BJ; Wang TF; Ren S; George G; Al Homssi A; Gaddh M; Connolly GC; Shah VI; Bogue T; Bartosic A; Neuberg D; Baumann Kreuziger L; Zwicker JI;
    Blood Adv; 2021 Dec; 5(24):5546-5553. PubMed ID: 34662892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus.
    Napolitano M; Saccullo G; Marietta M; Carpenedo M; Castaman G; Cerchiara E; Chistolini A; Contino L; De Stefano V; Falanga A; Federici AB; Rossi E; Santoro R; Siragusa S; ; ; De Stefano V; Falanga A; Tosetto A; Avvisati G; Carpenedo M; Federici AB; Marietta M; Napolitano M; Rossi E; Santoro C; Castaman G; Cerchiara E; Chistolini A; Contino L; Mazzucconi MG; Nichele I; Russo L; Santi R; Santoro RC; Siragusa S; Tagariello G
    Blood Transfus; 2019 May; 17(3):171-180. PubMed ID: 30418130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation management and related outcomes in patients with cancer-associated thrombosis and thrombocytopenia: A systematic review and meta-analysis.
    Wang TF; Carrier M; Carney BJ; Kimpton M; Delluc A
    Thromb Res; 2023 Jul; 227():8-16. PubMed ID: 37196605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of venous thromboembolism and use of anticoagulation in hematological malignancies: Critical review of the literature.
    Annibali O; Napolitano M; Avvisati G; Siragusa S
    Crit Rev Oncol Hematol; 2018 Apr; 124():41-50. PubMed ID: 29548485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of direct oral anticoagulants for venous thromboembolism and stroke prophylaxis in patients with hematologic malignancies.
    Kim S; Namba J; Goodman AM; Nguyen T; Saunders IM
    J Oncol Pharm Pract; 2020 Mar; 26(2):351-360. PubMed ID: 31142232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.